The FDA application complements recent label extension submissions to the EMA and Health Canada, highlighting Valneva's strategic push to enhance IXCHIQ's global reach.
The "Head and Neck Cancer Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Head and Neck Cancer Therapeutics is estimated at ...